Document is current
Any future updates will be listed below
-
Authors
Xiang, Lilin
Jia, Zhenhua
Yu, Zhangyi
Wang, Lenan
Cai, Huanhuan
Zhang, Tong
Lu, Zhibing
Wang, Li
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China Stem Cell and Translational Research (2021YFA1102500)
National Natural Science Foundation of China (32470787, 92068107 and 32070728)
Natural Science Foundation of Hubei Province (2023AFA059)
Fundamental Research Funds for the Central Universities in China (2042022kf0052 and 2042022dx0003)
Major Scientific and Technological Project of Hubei Province (2022ACA005)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 14 October 2025
First Online: 13 November 2025
Declarations
:
: The human embryonic stem cell line H7 used in this study was obtained from WiCell Research Institute. WiCell has confirmed that the derivation of the H7 cell line was conducted with prior ethical approval, and that informed consent was obtained from the donors at the time of cell collection. The human iPSC line WTC was obtained from fibroblast and from Gladstone Institute. Gladstone has confirmed that the derivation of the WTC cell line was conducted with prior ethical approval. Informed consent was also obtained from the donors at the time of cell collection.
: Not applicable.
: The authors declare no competing interests.
